Paul Cheng

5.3k total citations
80 papers, 2.2k citations indexed

About

Paul Cheng is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Paul Cheng has authored 80 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 15 papers in Pathology and Forensic Medicine and 14 papers in Oncology. Recurrent topics in Paul Cheng's work include Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Congenital heart defects research (9 papers). Paul Cheng is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Congenital heart defects research (9 papers). Paul Cheng collaborates with scholars based in United States, Hong Kong and China. Paul Cheng's co-authors include Deepak Srivastava, Chulan Kwon, Vishal Nigam, Thomas Quertermous, Peter Andersen, Robert Wirka, Qian Li, Ronald Witteles, Lincoln T. Shenje and Isabelle N. King and has published in prestigious journals such as Nature, Circulation and Nature Communications.

In The Last Decade

Paul Cheng

71 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Cheng United States	24	1.1k	338	336	333	271	80	2.2k
Jonathan H. Axelrod Israel	25	919 0.8×	367 1.1×	416 1.2×	259 0.8×	198 0.7×	45	2.2k
Robert K. Nuttall United Kingdom	24	761 0.7×	746 2.2×	593 1.8×	367 1.1×	245 0.9×	32	2.4k
Lingjuan He China	31	1.9k 1.7×	310 0.9×	286 0.9×	235 0.7×	838 3.1×	72	3.2k
Carolin Mogler Germany	29	1.1k 0.9×	436 1.3×	656 2.0×	397 1.2×	369 1.4×	126	2.7k
Yasuo Mori Japan	20	1.0k 0.9×	174 0.5×	462 1.4×	770 2.3×	308 1.1×	102	2.9k
Giovanni Ligresti United States	31	1.2k 1.0×	295 0.9×	411 1.2×	330 1.0×	246 0.9×	59	2.4k
Vineet Gupta United States	27	880 0.8×	239 0.7×	372 1.1×	756 2.3×	244 0.9×	68	2.5k
Emma C. Josefsson Australia	29	1.2k 1.1×	155 0.5×	312 0.9×	647 1.9×	251 0.9×	61	3.0k
Junhao Hu China	22	1.1k 0.9×	291 0.9×	502 1.5×	346 1.0×	305 1.1×	48	2.1k
Makoto Kubo Japan	30	1.3k 1.1×	571 1.7×	918 2.7×	502 1.5×	198 0.7×	126	3.0k

Countries citing papers authored by Paul Cheng

Since Specialization

Citations

This map shows the geographic impact of Paul Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Cheng more than expected).

Fields of papers citing papers by Paul Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Cheng. The network helps show where Paul Cheng may publish in the future.

Co-authorship network of co-authors of Paul Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Cheng. A scholar is included among the top collaborators of Paul Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Cheng. Paul Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Manhas, Amit, Yu Liu, Chikage Noishiki, et al.. (2025). Multiscale profiling of tyrosine kinase inhibitor cardiotoxicity reveals mechanosensitive ion channel PIEZO1 as cardioprotective. Science Translational Medicine. 17(829). eadv9403–eadv9403.

Chiu, I-Min, Neal Yuan, Tien‐Yu Chen, et al.. (2025). Comprehensive echocardiogram evaluation with view primed vision language AI. Nature. 650(8103). 970–977. 1 indexed citations

Albayrak, Yavuz, Daniel González, E Sun, et al.. (2025). PO-05-050 PREDICTORS OF ATRIAL FIBRILLATION IN PATIENTS ON NON-BRUTON’S TYROSINE KINASE INHIBITORS. Heart Rhythm. 22(4). S584–S585.

Spencer‐Bonilla, Gabriela, Jun Fan, Paul Cheng, et al.. (2025). Delayed Diagnosis of Transthyretin Amyloid Cardiomyopathy in the Veterans Health Administration. Journal of the American College of Cardiology. 87(5). 533–545. 1 indexed citations

Locke, Frederick L., Olalekan O. Oluwole, John Kuruvilla, et al.. (2023). Association of Metabolic Tumor Volume (MTV) and Clinical Outcomes in Second-Line (2L) Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL) Following Axicabtagene Ciloleucel (Axi-Cel) Versus Standard-of-Care (SOC) Therapy in Zuma-7. Transplantation and Cellular Therapy. 29(2). S372–S372. 1 indexed citations

Kalkman, Eric R., Mary T. Scott, Karen Dunn, et al.. (2023). Arginine dependency is a therapeutically exploitable vulnerability in chronic myeloid leukaemic stem cells. EMBO Reports. 24(10). e56279–e56279. 5 indexed citations

Kersten, Marie José, Ruchit Shah, Caitlyn T. Solem, et al.. (2023). Quality-Adjusted Time without Symptoms or Toxicity: Analysis of Axicabtagene Ciloleucel versus Standard of Care in Patients with Relapsed/Refractory Large B Cell Lymphoma. Transplantation and Cellular Therapy. 29(5). 335.e1–335.e8. 3 indexed citations

Kilgore, Karl M., et al.. (2021). Burden of Illness and Outcomes in Second-Line Large B-Cell Lymphoma Treatment: Real-World Analysis of Medicare Beneficiaries. Future Oncology. 17(35). 4837–4847. 3 indexed citations

Duffy, Grant, Paul Cheng, Bryan He, et al.. (2021). Abstract 12669: Precision Phenotyping of Left Ventricular Hypertrophy With Echocardiographic Deep Learning. Circulation. 144(Suppl_1). 1 indexed citations

10.

Zhao, Quanyi, Michael Dacre, Trieu Nguyen, et al.. (2020). Molecular mechanisms of coronary disease revealed using quantitative trait loci for TCF21 binding, chromatin accessibility, and chromosomal looping. Genome biology. 21(1). 135–135. 13 indexed citations

11.

Kim, Juyong Brian, Quanyi Zhao, Trieu Nguyen, et al.. (2020). Environment-Sensing Aryl Hydrocarbon Receptor Inhibits the Chondrogenic Fate of Modulated Smooth Muscle Cells in Atherosclerotic Lesions. Circulation. 142(6). 575–590. 63 indexed citations

12.

Cheng, Paul, Han Zhu, Ronald Witteles, et al.. (2020). Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty. Current Cardiology Reports. 22(5). 34–34. 49 indexed citations

13.

Zhao, Quanyi, Robert Wirka, Trieu Nguyen, et al.. (2019). TCF21 and AP-1 interact through epigenetic modifications to regulate coronary artery disease gene expression. Genome Medicine. 11(1). 23–23. 37 indexed citations

14.

Nagao, Manabu, Qing Lyu, Quanyi Zhao, et al.. (2019). Coronary Disease-Associated Gene TCF21 Inhibits Smooth Muscle Cell Differentiation by Blocking the Myocardin-Serum Response Factor Pathway. Circulation Research. 126(4). 517–529. 62 indexed citations

15.

Kuttke, Mario, Angela Halfmann, Alexander Dohnal, et al.. (2014). Correction: Macrophage PTEN Regulates Expression and Secretion of Arginase I Modulating Innate and Adaptive Immune Responses. The Journal of Immunology. 193(10). 5350–5350. 4 indexed citations

16.

Hassel, David, Paul Cheng, Mark P. White, et al.. (2012). MicroRNA-10 Regulates the Angiogenic Behavior of Zebrafish and Human Endothelial Cells by Promoting Vascular Endothelial Growth Factor Signaling. Circulation Research. 111(11). 1421–1433. 64 indexed citations

17.

Kwon, Chulan, Paul Cheng, Isabelle N. King, et al.. (2011). Notch post-translationally regulates β-catenin protein in stem and progenitor cells. Nature Cell Biology. 13(10). 1244–1251. 232 indexed citations

18.

Laake, Linda W. van, Qian Li, Paul Cheng, et al.. (2010). Reporter-Based Isolation of Induced Pluripotent Stem Cell– and Embryonic Stem Cell–Derived Cardiac Progenitors Reveals Limited Gene Expression Variance. Circulation Research. 107(3). 340–347. 42 indexed citations

19.

Ho, Stephen, et al.. (1995). Germ cell tumors express a specific alpha-fetoprotein variant detectable by isoelectric focusing. Cancer. 75(7). 1663–1668. 14 indexed citations

20.

Goetzl, E J, Paul Cheng, Avi Hassner, et al.. (1990). Neuropeptides, mast cells and allergy: novel mechanisms and therapeutic possibilities. Clinical & Experimental Allergy. 20(s4). 3–7. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact